Bonaccorso Joe 4/A
4/A · Verrica Pharmaceuticals Inc. · Filed Feb 6, 2025
Insider Transaction Report
Form 4/AAmended
Bonaccorso Joe
CHIEF COMMERCIAL OFFICER
Transactions
- Award
Common Stock
2023-08-24+125,000→ 187,738 total
Footnotes (2)
- [F1]Represents restricted stock unit ("RSU") awards with performance based vesting, which were originally granted in March 2023. The RSUs vested 50% upon the first commercial sale of VP-102 on August 24, 2023, and the remaining 50% vested on August 24, 2024, the one year anniversary of the first sale.
- [F2]The number of RSUs awarded in the initial Form 4 was unintentionally misreported, as only the number of shares that vested on August 24, 2023 were reported as opposed to the full size of the award. This amendment corrects the number RSUs awarded and the number of securities beneficially owned after the reported transaction.